(PDF) 141 Soluble Receptor Activator of Nuclear Factor Κ B

141 Soluble Receptor Activator of Nuclear Factor Κ B Ligand (S RANK-L) Levels in Paediatric Onset SLE

doi 10.1136/lupus-2017-000215.141

Full Text

Open PDF

Abstract

Available in full text

Date

March 1, 2017

Authors

Publisher

Lupus Foundation of America

Related search

SERUM LEVELS OF SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR- KAPPA-B Ligand (S-Rankl) IN PATIENTS WITH DIFUSSE IDIOPATHIC SKELETAL HYPEROSTOSIS AND ANKILOSING SPONDILITIS

Knowledge International Journal

2018

English

Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)/RANK Signaling Promotes Cancer-Related Inflammation Through M2 Macrophages

Experimental Dermatology

English

Osteoprotegerin, Receptor Activator of Nuclear Factor kB and Receptor Activator of Nuclear Factor κB Ligand and Bone Mineralization in Children With Inflammatory Bowel Diseases

Przeglad Gastroenterologiczny

Gastroenterology

2011

English

Marginal Jawbone Loss Is Associated With Onset of Rheumatoid Arthritis and Is Related to Plasma Level of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)

Arthritis and Rheumatology

English

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Directly Modulates the Gene Expression Profile of RANK-positive Saos-2 Human Osteosarcoma Cells

English

The Possible Interaction Between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and Its Ligand on Dermal Macrophages

Journal of Investigative Dermatology

English

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Protects Against Hepatic Ischemia/Reperfusion Injury in Mice

English

Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines

Mediators of Inflammation

Immunology

Cell Biology

2019

English

Mycobacterium Tuberculosis 10-kDa Co-Chaperonin Regulates the Expression Levels of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Human Osteoblasts

Experimental and Therapeutic Medicine

English

Amanote Research

141 Soluble Receptor Activator of Nuclear Factor Κ B Ligand (S RANK-L) Levels in Paediatric Onset SLE

doi 10.1136/lupus-2017-000215.141

Full Text

Abstract

Date

Authors

Publisher

Related search

SERUM LEVELS OF SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR- KAPPA-B Ligand (S-Rankl) IN PATIENTS WITH DIFUSSE IDIOPATHIC SKELETAL HYPEROSTOSIS AND ANKILOSING SPONDILITIS

Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)/RANK Signaling Promotes Cancer-Related Inflammation Through M2 Macrophages

Osteoprotegerin, Receptor Activator of Nuclear Factor kB and Receptor Activator of Nuclear Factor κB Ligand and Bone Mineralization in Children With Inflammatory Bowel Diseases

Marginal Jawbone Loss Is Associated With Onset of Rheumatoid Arthritis and Is Related to Plasma Level of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Directly Modulates the Gene Expression Profile of RANK-positive Saos-2 Human Osteosarcoma Cells

The Possible Interaction Between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and Its Ligand on Dermal Macrophages

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Protects Against Hepatic Ischemia/Reperfusion Injury in Mice

Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines

Mycobacterium Tuberculosis 10-kDa Co-Chaperonin Regulates the Expression Levels of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Human Osteoblasts